Madagascar Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Madagascar Health Press.

Press releases published on July 30, 2026

33 minutes ago

Press Release: Sanofi’s half-year financial report for 2026

Indeterminate GlobeNewswire

33 minutes ago

Communiqué de presse : Rapport financier semestriel 2026 de Sanofi

Indeterminate GlobeNewswire

41 minutes ago

Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel

Indeterminate GlobeNewswire

an hour ago

WellSpan expands Hippocratic AI partnership to support clinical operations and improve patient experience

Indeterminate GlobeNewswire

an hour ago

Lice Clinics of America Returns to the Treasure Valley Ahead of Back-to-School Season

Indeterminate GlobeNewswire

an hour ago

Diakonos Oncology Announces First Patients Dosed in Phase 1/2 DOC-RM Study of DOC1021 in Refractory Melanoma

Indeterminate GlobeNewswire

an hour ago

IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer

Indeterminate GlobeNewswire

2 hours ago

20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour

Indeterminate GlobeNewswire

2 hours ago

SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET

Indeterminate GlobeNewswire

2 hours ago

Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference

Indeterminate GlobeNewswire

2 hours ago

Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

2 hours ago

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Indeterminate GlobeNewswire

2 hours ago

Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

Indeterminate GlobeNewswire

2 hours ago

Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

2 hours ago

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

Indeterminate GlobeNewswire

2 hours ago

NewGen Provides Update on K25.ai Investment and Strengthened Financial Position

Indeterminate GlobeNewswire

2 hours ago

Clearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial

Indeterminate GlobeNewswire

2 hours ago

NurExone Launches Bioprocess Optimization Initiative to Support Commercial and Clinical Readiness

Indeterminate GlobeNewswire

2 hours ago

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

Indeterminate GlobeNewswire

2 hours ago

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire